English
Human Apo CIII
Human Apo CIII
Artikelnummer
BEYP81-116-0.5MG
Verpackungseinheit
0.5 mg
Hersteller
Bethyl Laboratories
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Stock Concentration: 1 mg/ml
Conjugate Type: Unconjugated
Buffer: 10 mM Tris-HCl, 0.15 M NaC1, 0.5 mM EDTA, 0.02% NaN3, pH 8.0
Shelf Life: 1 year from date of receipt
Background: Apo CIII contains 79 amino acid residues. The m.w. is 8.7 kDa (Brewer et al., 1974). It may inhibit the activation of lipoprotein lipase by apo CIII. Apo CIII is a constituent of both apoB- and apoAI-containing lipoproteins in the circulation. Apo CIII plays a pivotal role in regulating the plasma metabolism of VLDL, IDL, and LDL, primarily by inhibiting receptor-mediated uptake of these lipoproteins by the liver. (Sehayek and Eisenberg 1991, Aalto-Setala et al., 1992, Zheng et al., 2007)
Conjugate Type: Unconjugated
Buffer: 10 mM Tris-HCl, 0.15 M NaC1, 0.5 mM EDTA, 0.02% NaN3, pH 8.0
Shelf Life: 1 year from date of receipt
Background: Apo CIII contains 79 amino acid residues. The m.w. is 8.7 kDa (Brewer et al., 1974). It may inhibit the activation of lipoprotein lipase by apo CIII. Apo CIII is a constituent of both apoB- and apoAI-containing lipoproteins in the circulation. Apo CIII plays a pivotal role in regulating the plasma metabolism of VLDL, IDL, and LDL, primarily by inhibiting receptor-mediated uptake of these lipoproteins by the liver. (Sehayek and Eisenberg 1991, Aalto-Setala et al., 1992, Zheng et al., 2007)
| Artikelnummer | BEYP81-116-0.5MG |
|---|---|
| Hersteller | Bethyl Laboratories |
| Hersteller Artikelnummer | P81-116-0.5MG |
| Verpackungseinheit | 0.5 mg |
| Mengeneinheit | STK |
| Wirt | Human |
| Produktinformation (PDF) |
|
| MSDS (PDF) |
|
Verwandte Artikel
Markieren Sie die Artikel, um Sie dem Warenkorb hinzuzufügen oder
Immer für Sie da
Gernot Ensinger, M.Sc.
Laurent Haze
